维普期刊资源整合服务平台（V6.5）

160篇 您的检索式：作者名="WAHL RL"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors显示文摘	WAHL RL JACENE H KASAMON Y	2009	J Nucl Med2009，50，1：	1
2	'Anatometabolic' tumor imaging: fusion of FI PET with CT or MRI to localize loci or increased activity 显示文摘	Wahl RL Quint LE Cieslak RD	1993	J Nucl Med1993，34，11：	1
3	Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements显示文摘	Cohade C Wahl RL	2003	Semin Nucl Med2003，33，3：	1
4	Metabolic monitoring of breast cancer chemohormontherapy using positron emission tomography initial evaluation显示文摘	Wahl RL Zasadny K Helvie M	1993	J Clin Oncol1993，11，11：	1
5	Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia 显示文摘	Clavo AC Brown RS Wahl RL	1995	J Nucl Med1995，36，9：	1
6	Staging non-small cell lung cancer with FDG-PET,CT and fusion images:preliminary prospective evaluation显示文摘	Wahl RL Quint LE Greenough RL	1994	Radiology1994，191，：	1
7	From RECIST to PERCIST:Evolving Considerations for PET response criteria in solid tumors显示文摘	Wahl RL Jacene H Kasamon Y	2009	J Nucl Med2009，501，：	1
8	Diagnosis and differentiation of bronchioloalveolar carcinoma t~om adenocarcinoma with bronchiol- oalveolar components with metabolic and anatomic characteristics using PET/CT显示文摘	Goudar'A B Jacene HA Wahl RL	2008	J Nucl Med2008，49，：	1
9	Prospective multicenter study of axillary nodal staging by positron emission tomog-raphy in breast cancer:a report of the staging breast cancer with PET Study Group显示文摘	Wahl RL Siegel BA Coleman RE	2004	J Clin Oncol2004，22，2：	1
10	Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants显示文摘	Shreve PD Anzai Y Wahl RL	1999	Radiographics1999，19，1：	1
11	From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors显示文摘	Wahl RL Jacene H Kasamon Y	2009	J Nucl Med2009，50，1：	1
12	From RECIST to PERCIST:evolving considerations for PET response crite- ria in solid tumors显示文摘	Wahl RL Jacene H Kasamon Y	2009	J Nucl Med2009，501，：	1
13	Integrating PET and PET/CT into the risk-adapted therapy of lymphoma 显示文摘	Kasarnon YL Jones RJ Wahl RL	2007	J Nuel Med2007，48，1：	1
14	Overview of the current status of PET in breast cancer imaging 显示文摘	Wahl RL	1998	Q J Nucl Med1998，42，1：	1
15	Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer : a report of the staging breast cancer with PET study group 显示文摘	Wahl RL Siegel BA Coleman RE	2004	J Clin Oncol2004，22，2：	1
16	'USA Fat': prevalence is related to ambient outdoor temperature evaluation with SF FDG PET/CT显示文摘	Cohade C Mourtzikos KA Wahl RL	2003	J Nucl Meal2003，44，8：	1
17	Current status of PET in breast cancer imping, staging, and therapy显示文摘	Wahl RL	2001	Semin Roentgenol2001，36，：	1
18	Standardized uptake values of normal tissues at PET with 2-fluorine-18-fluoro-2-deoxy-D-glucose:variations with body weight and a method for correction显示文摘	Zasadny KR Wahl RL	1993	Radiology1993，189，3：	1
19	FDG-PET imaging of ovarian cancer: initial evaluation in patients 显示文摘	Wahl RL Hutchins G Roberts J	1991	J Nucl Med1991，，：	1
20	Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt' s lymphoma xenografts 显示文摘	Buchsbaum DJ Wahl RL Normolle DP	1992	Cancer Res1992，52，23：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示